Rapport Therapeutics Inc (RAPP)
Investing Cash Flow
-$167.56M
TTM · Period ending: · USD
RAPP Investing Cash Flow
Latest reported-$167.56Mperiod ending
Latest reported-$167.56Mperiod ending
RAPP TTM Cash from Investing (-$78.86M → -$167.56M)
TTM investing cash flow
High-resolution chart · PNG
RAPP investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -167,559,000 | |
| -170,563,000 | |
| -187,473,000 | |
| 18,781,000 | |
| 22,516,000 | |
| -107,184,000 | |
| -170,141,000 | |
| -280,732,000 | |
| -227,743,000 | |
| -120,725,000 | |
| -78,860,000 |